Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionImpax Asset Management Group plc
Latest Disclosed Ownership210,813 shares
Latest Disclosed Value $ 29,381,008
Impax Asset Management Group plc reports 28.92% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 12, 2026 - Impax Asset Management Group plc filed a 13F-HR form disclosing ownership of 210,813 shares of Gilead Sciences, Inc. (CH:GILD) valued at $29,381,008 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 296,565 shares of Gilead Sciences, Inc.. This represents a change in shares of -28.92% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Gilead Sciences Common Stock 375558103 210,813 -85,752 -28.92 29,381 -19.28 0.2048
2026-01-29 2025-12-31 13F Gilead Sciences Common Stock 375558103 296,565 19,894 7.19 36,400 18.53 0.2277
2025-11-06 2025-09-30 13F Gilead Sciences Common Stock 375558103 276,671 -17,942 -6.09 30,710 -5.98 0.1792
2025-08-08 2025-06-30 13F Gilead Sciences Common Stock 375558103 294,613 10,607 3.73 32,664 2.64 0.1878
2025-04-29 2025-03-31 13F Gilead Sciences Common Stock 375558103 284,006 -96,564 -25.37 31,823 -9.48 0.1916
2025-02-04 2024-12-31 13F Gilead Sciences Common Stock 375558103 380,570 212,828 126.88 35,153 149.97 0.1592
2024-11-06 2024-09-30 13F/A-1 Gilead Sciences Common Stock 375558103 167,742 -7,979 -4.54 14,063 16.65 0.0554
2024-10-30 2024-09-30 13F Gilead Sciences Common Stock 375558103 167,742 -7,979 14,063 0.0554
2024-11-08 2024-06-30 13F/A-1 Gilead Sciences Common Stock 375558103 175,721 49,920 39.68 12,056 30.84 0.0491
2024-08-05 2024-06-30 13F Gilead Sciences Common Stock 375558103 175,721 49,920 12,056 0.0491
2024-04-30 2024-03-31 13F Gilead Sciences Common Stock 375558103 125,801 -37,289 -22.86 9,215 -30.26 0.0353
2024-01-26 2023-12-31 13F Gilead Sciences Common Stock 375558103 163,090 -327 -0.20 13,212 7.88 0.0530
2023-11-07 2023-09-30 13F/A-1 Gilead Sciences Common Stock 375558103 163,417 53,704 48.95 12,246 44.84 0.0547
2023-11-07 2023-09-30 13F Gilead Sciences Common Stock 375558103 163,417 12,246
2023-08-07 2023-06-30 13F Gilead Sciences Common Stock 375558103 109,713 668 0.61 8,456 -6.54 0.0340
2023-05-10 2023-03-31 13F Gilead Sciences Common Stock 375558103 109,045 69,533 175.98 9,047 166.72 0.0378
2023-02-09 2022-12-31 13F Gilead Sciences Common Stock 375558103 39,512 2 0.01 3,392 39.19 0.0152
2022-11-08 2022-09-30 13F Gilead Sciences Common Stock 375558103 39,510 -887 -2.20 2,437 -2.40 0.0125
2022-08-11 2022-06-30 13F/A-2 Gilead Sciences Common Stock 375558103 40,397 -4,047 -9.11 2,497 -5.49 0.0122
2022-08-02 2022-06-30 13F Gilead Sciences Common Stock 375558103 44,444 0 2,642 0.0109
2022-05-16 2022-03-31 13F Gilead Sciences Common Stock 375558103 44,444 2,986 7.20 2,642 -12.23 0.0109
2022-02-14 2021-12-31 13F Gilead Sciences Common Stock 375558103 41,458 1,257 3.13 3,010 7.19 0.0110
2021-11-12 2021-09-30 13F Gilead Sciences Common Stock 375558103 40,201 149 0.37 2,808 1.81 0.0115
2021-08-05 2021-06-30 13F Gilead Sciences Common Stock 375558103 40,052 -17 -0.04 2,758 6.49 0.0122
2021-05-14 2021-03-31 13F Gilead Sciences Common Stock 375558103 40,069 1,996 5.24 2,590 16.77 0.0133
2021-02-16 2020-12-31 13F Gilead Sciences Common Stock 375558103 38,073 3,189 9.14 2,218 0.64 0.0141
2020-11-12 2020-09-30 13F Gilead Sciences Common Stock 375558103 34,884 1,067 3.16 2,204 -15.30 0.0193
2020-08-14 2020-06-30 13F Gilead Sciences Common Stock 375558103 33,817 874 2.65 2,602 5.64 0.0267
2020-05-15 2020-03-31 13F Gilead Sciences Common Stock 375558103 32,943 5,361 19.44 2,463 37.44 0.0328
2020-02-13 2019-12-31 13F Gilead Sciences Common Stock 375558103 27,582 27,582 1,792 0.0200
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.